GL1X · GenesisL1 explorer

Research workbench

Structure of full-length CD20 in complex with rituximab Fab

Analyse Structure of full-length CD20 in complex with rituximab Fab in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6Y90
Type
protein
Length
1,218 residues
Chains
6
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
B-lymphocyte antigen CD20; Rituximab Fab heavy chain; Rituximab Fab light chain
UniProt
P11836
Ligands
MYS, Y01, PC1
Pockets
17 · best druggability 0.87

Structure

electron microscopy · 3 distinct chains · 21% helix, 33% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BB-lymphocyte antigen CD20protein17267% helix, 0% strandP11836
C, HRituximab Fab heavy chainprotein2240% helix, 46% strand—
D, LRituximab Fab light chainprotein2137% helix, 46% strand—

Ligands and binding sites

  • MYS · Pentadecane · ligand · 10 copies · chains A, B
  • Y01 · Cholesterol hemisuccinate · ligand · 8 copies · chains A, B
  • PC1 · 1,2-diacyl-sn-glycero-3-phosphocholine · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

17 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15450.870.9360empty
21190.620.8724empty
31100.610.8720empty
45690.600.7458empty
55430.600.7461empty

Interfaces

14 interfaces between chains.

  • H–L · 2001 Ų buried · 15 hydrogen bonds · protein-protein
  • C–D · 2000 Ų buried · 14 hydrogen bonds · protein-protein
  • A–B · 1638 Ų buried · 6 hydrogen bonds · protein-protein
  • B–C · 494 Ų buried · 6 hydrogen bonds · protein-protein
  • A–H · 489 Ų buried · 7 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 12 disulfide, 2 covalent (disulfide, covalent ligand).

Compared structures

  • 6Y90 · Structure of full-length CD20 in complex with Rituximab Fab · the same entry in another collection · chain L against L, TM-score 1.00
  • P11836 · AlphaFold monomer V2.0 prediction for B-lymphocyte antigen CD20 (P11836) · a predicted model of the same protein · chain B against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.